Cargando…
Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution?
Critical historical analysis of the 19th-century cholera and 21st-century coronavirus-19 (COVID-19) pandemics suggests that in conflicts over pandemic-mitigation policies, the professional backgrounds of principal opponents reveal dominant and minority scientific paradigms, presaging possible episte...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882036/ https://www.ncbi.nlm.nih.gov/pubmed/35231588 http://dx.doi.org/10.1016/j.annepidem.2022.02.005 |
_version_ | 1784659610770079744 |
---|---|
author | Fairman, Kathleen A. |
author_facet | Fairman, Kathleen A. |
author_sort | Fairman, Kathleen A. |
collection | PubMed |
description | Critical historical analysis of the 19th-century cholera and 21st-century coronavirus-19 (COVID-19) pandemics suggests that in conflicts over pandemic-mitigation policies, the professional backgrounds of principal opponents reveal dominant and minority scientific paradigms, presaging possible epistemological shifts. Epistemic conflict over cholera helped spur biomedical expertise as the dominant paradigm for U.S. public health science and policy beginning in the 20th century. This paradigm was reflected in federal government reliance on infectious disease physicians as the primary scientific decision makers in the COVID-19 pandemic. Similarly, epistemic conflict over challenges to behavioral and social well-being in 2020 may highlight discordance between the dominant biomedical paradigm used in making federal policy and the inherently holistic impact of that policy on population health, suggesting need for a new paradigm of multidisciplinary scientific engagement. Because population-wide public health initiatives affect many aspects of health—physiological, psychological, behavioral, and social—that are best measured and interpreted by experts in these respective fields, multidisciplinary scientific engagement would facilitate optimal, holistic evaluation of policy benefits and harms. This multidisciplinary approach, analogous to that currently recommended in medical management of chronic disease, would advance epidemiological research to inform evidence-based policy for public health crises in which U.S. population-wide interventions are contemplated. |
format | Online Article Text |
id | pubmed-8882036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88820362022-02-28 Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution? Fairman, Kathleen A. Ann Epidemiol Commentary Critical historical analysis of the 19th-century cholera and 21st-century coronavirus-19 (COVID-19) pandemics suggests that in conflicts over pandemic-mitigation policies, the professional backgrounds of principal opponents reveal dominant and minority scientific paradigms, presaging possible epistemological shifts. Epistemic conflict over cholera helped spur biomedical expertise as the dominant paradigm for U.S. public health science and policy beginning in the 20th century. This paradigm was reflected in federal government reliance on infectious disease physicians as the primary scientific decision makers in the COVID-19 pandemic. Similarly, epistemic conflict over challenges to behavioral and social well-being in 2020 may highlight discordance between the dominant biomedical paradigm used in making federal policy and the inherently holistic impact of that policy on population health, suggesting need for a new paradigm of multidisciplinary scientific engagement. Because population-wide public health initiatives affect many aspects of health—physiological, psychological, behavioral, and social—that are best measured and interpreted by experts in these respective fields, multidisciplinary scientific engagement would facilitate optimal, holistic evaluation of policy benefits and harms. This multidisciplinary approach, analogous to that currently recommended in medical management of chronic disease, would advance epidemiological research to inform evidence-based policy for public health crises in which U.S. population-wide interventions are contemplated. Elsevier Inc. 2022-05 2022-02-26 /pmc/articles/PMC8882036/ /pubmed/35231588 http://dx.doi.org/10.1016/j.annepidem.2022.02.005 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Fairman, Kathleen A. Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution? |
title | Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution? |
title_full | Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution? |
title_fullStr | Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution? |
title_full_unstemmed | Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution? |
title_short | Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution? |
title_sort | pandemics, policy, and the power of paradigm: will covid-19 lead to a new scientific revolution? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882036/ https://www.ncbi.nlm.nih.gov/pubmed/35231588 http://dx.doi.org/10.1016/j.annepidem.2022.02.005 |
work_keys_str_mv | AT fairmankathleena pandemicspolicyandthepowerofparadigmwillcovid19leadtoanewscientificrevolution |